Merbecovirus S2 subunit vaccines elicit cross reactive antibodies and provide partial protection against MERS coronavirus.

Publication date: Jul 29, 2025

Since the outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV), a virus that has caused a high case fatality rate of 36%, other merbecoviruses have been reported to also be capable of infecting human cells. Given the threat of Merbecovirus spillover to humans, we developed virus-like particle vaccines presenting the S2 subunit proteins of MERS-CoV, NeoCoV, HKU4, or HKU25. Mice were vaccinated with the homotypic vaccines, and IgG endpoint titers were measured against S2 proteins of the same panel of viruses, confirming high cross-reactivity across all four viruses. Based on characterization by antigenic cartography, MERS-CoV and HKU4 S2 proteins were selected as optimal components for a cocktail vaccine. MERS-CoV and NeoCoV homotypic vaccines, along with the mixture vaccine, provided partial protection in transgenic mice against a MERS-CoV challenge. These findings could serve as an important step toward designing pan-Merbecovirus vaccines in preparation for future outbreaks.

Open Access PDF

Concepts Keywords
Cartography Coronavirus
Cocktail Cov
Merbecoviruses Cross
Optimal High
Vaccinated Hku4
Homotypic
Merbecovirus
Mers
Neocov
Partial
Protection
Subunit
Vaccines
Virus
Viruses

Semantics

Type Source Name
disease MESH Middle East respiratory syndrome
disease MESH severe acute respiratory syndrome
disease MESH mutation rate
disease MESH Influenza
disease MESH Viral Diseases
disease MESH Infection
drug DRUGBANK Coenzyme M
disease IDO host
disease MESH SD1
disease IDO assay
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Tretamine
drug DRUGBANK Proline
disease IDO immune response
drug DRUGBANK Tromethamine
drug DRUGBANK Trestolone
drug DRUGBANK Flunarizine
drug DRUGBANK Isoflurane
drug DRUGBANK Dextrose unspecified form
disease IDO colony
drug DRUGBANK Aspartame
drug DRUGBANK Methylcellulose
disease MESH emergencies
disease IDO cell
drug DRUGBANK Trypsin
disease IDO protein
disease MESH syndrome
disease MESH acute respiratory distress syndrome
drug DRUGBANK Biotin
disease MESH Allergy
disease MESH Infectious Diseases
disease MESH Reemerging Infectious Diseases
pathway REACTOME Reproduction

Original Article

(Visited 2 times, 1 visits today)